Copeland Capital Management LLC Cuts Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Copeland Capital Management LLC cut its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 13.9% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 36,868 shares of the healthcare conglomerate's stock after selling 5,958 shares during the period. Copeland Capital Management LLC's holdings in UnitedHealth Group were worth $18,650,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Quarry LP lifted its position in UnitedHealth Group by 132.1% during the second quarter. Quarry LP now owns 65 shares of the healthcare conglomerate's stock valued at $33,000 after buying an additional 37 shares during the period. AMF Tjanstepension AB raised its stake in UnitedHealth Group by 88.0% during the third quarter. AMF Tjanstepension AB now owns 258,833 shares of the healthcare conglomerate's stock valued at $151,374,000 after buying an additional 121,180 shares during the last quarter. Czech National Bank increased its holdings in shares of UnitedHealth Group by 7.3% during the third quarter. Czech National Bank now owns 188,110 shares of the healthcare conglomerate's stock valued at $109,984,000 after acquiring an additional 12,721 shares in the last quarter. Alpha Omega Wealth Management LLC purchased a new stake in UnitedHealth Group during the 3rd quarter valued at about $213,000. Finally, Apella Capital LLC grew its holdings in shares of UnitedHealth Group by 6.0% during the third quarter. Apella Capital LLC now owns 1,187 shares of the healthcare conglomerate's stock valued at $703,000 after buying an additional 67 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Trading Down 1.4 %

UNH traded down $7.63 during trading hours on Wednesday, reaching $537.82. 3,285,967 shares of the company's stock traded hands, compared to its average volume of 4,405,931. The firm has a market capitalization of $494.94 billion, a PE ratio of 34.67, a PEG ratio of 1.48 and a beta of 0.61. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The firm has a 50-day moving average price of $533.81 and a 200 day moving average price of $564.94. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion during the quarter, compared to analysts' expectations of $101.60 billion. During the same period in the prior year, the business earned $5.83 EPS. The business's revenue for the quarter was up 6.8% compared to the same quarter last year. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.63 EPS for the current fiscal year.

Insider Buying and Selling at UnitedHealth Group

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the business's stock in a transaction on Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares of the company's stock, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 0.33% of the company's stock.

Analysts Set New Price Targets

UNH has been the subject of a number of research analyst reports. Deutsche Bank Aktiengesellschaft lifted their target price on UnitedHealth Group from $595.00 to $625.00 and gave the stock a "buy" rating in a report on Tuesday, December 3rd. UBS Group decreased their price objective on shares of UnitedHealth Group from $680.00 to $650.00 and set a "buy" rating for the company in a report on Wednesday, October 16th. Truist Financial dropped their price target on UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating on the stock in a research note on Monday, January 6th. Hsbc Global Res raised UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research report on Friday, January 10th. Finally, Royal Bank of Canada cut their target price on shares of UnitedHealth Group from $615.00 to $595.00 and set an "outperform" rating for the company in a research report on Wednesday, October 16th. One equities research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Buy" and an average price target of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.